XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net loss $ (1,861,109) $ (782,093)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 79,750 77,208
Accretion of note payable discount 4,609 5,250
Non cash interest expense 87,140 141,211
Stock based compensation 331,802 107,972
Non cash lease expense (67) 983
Provision for bad debt and write-off of on uncollectable accounts 23,380 22,712
Changes in operating assets and liabilities:    
Accounts receivable 4,532 88,645
Inventory (46,302) (91,874)
Prepaid expenses (166,598) 95,358
Deferred revenue (10,395)
Due to related parties (43,034)
Accounts payable and accrued liabilities (66,038) 100,472
Net cash used in operating activities (1,662,330) (234,156)
Investing activities    
Purchase of property and equipment (9,065) (1,015)
Net cash used in investing activities (9,065) (1,015)
Financing activities    
Payments for deferred offering costs (124,824)
Proceeds from issuance of loans from related parties 232,193 11,506
Proceeds from subscription advance 300,000
Payments of notes payable (316,920)
Net cash used in financing activities 215,273 (113,318)
Net decrease in cash (1,456,122) (348,489)
Cash and cash equivalents at beginning of period 2,016,611 393,194
Cash and cash equivalents at the end of period 560,489 44,705
Supplementary cash flow disclosure    
Interest paid 29,379 706
Unpaid deferred offering costs $ 204,060